[contentcards url=”https://childrenshealthdefense.org/defender/pfizer-rsv-vaccine-guillain-barre-syndrome-older-adults/” target=”_blank”] People who receive Pfizer’s respiratory syncytial virus vaccine should be monitored for Guillain-Barré syndrome, according to the authors of a Pfizer-funded study…

